BioMedicine-Taiwan, published by DIGITAL COMMONS BEPRESS, stands as a prominent open-access journal that has been disseminating vital research since 2014. With an ISSN of 2211-8020 and E-ISSN 2211-8039, this journal covers a wide array of disciplines within the biomedical field, reaching researchers and professionals keen on exploring cutting-edge advancements and innovative approaches in biochemistry, genetics, and general medicine. Notably categorized as Q2 in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine for 2023, BioMedicine-Taiwan ranks well in its respective fields, reflecting its commitment to enhancing scholarly communication and knowledge dissemination. Situated in Taiwan, its impact is further highlighted by its Scopus rankings—placing it in the 70th percentile for general medicine and 47th percentile for general biochemistry and molecular biology, showcasing its significance in ongoing biomedical discourse. Researchers, students, and professionals are invited to engage with this invaluable resource to explore the latest findings and developments that shape the future of healthcare and biological sciences.

CienciaUat is a distinguished academic journal published by the Universidad Autónoma de Tamaulipas, dedicated to fostering innovative research across various scientific disciplines. With an ISSN of 2007-7521 and an E-ISSN of 2007-7858, this journal serves as a platform for the dissemination of high-quality research findings that contribute to the advancement of science and technology within both local and international contexts. The journal aims to promote scholarly communication among researchers, professionals, and students, emphasizing the importance of empirical evidence and interdisciplinary approaches. Though specific metrics like H-Index and Scopus rankings are currently not provided, CienciaUat is committed to maintaining rigorous peer-review standards. The journal’s open-access model facilitates wide accessibility, ensuring that pivotal research reaches a global audience. The editorial team encourages submissions that adhere to the highest academic standards, reflecting innovation and relevance in today’s scientific landscape.

PLOS BIOLOGY, published by PUBLIC LIBRARY SCIENCE, is a leading open-access journal that has been at the forefront of biological research since its inception in 2003. This high-impact journal (with an impressive Scopus ranking placing it in the top 10% across multiple biological disciplines) aims to disseminate groundbreaking research findings in a variety of fields, including Biochemistry, Genetics, Molecular Biology, Immunology, Microbiology, and Neuroscience. With a commitment to open-access principles, PLOS BIOLOGY ensures that its content is freely available to a global audience, fostering collaboration and innovation among researchers, professionals, and students worldwide. Its Q1 quartile status in 2023 highlights the journal's prestigious standing within the academic community, making it an essential resource for those seeking to stay updated with the latest advancements in biological sciences. The journal's scope extends from 2003 to 2024, reflecting its sustained relevance and impact in driving forward biological discoveries.

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

BMC Medicine is a prestigious, peer-reviewed journal published by BMC, specializing in the rapidly evolving field of medicine. Launched in 2003, this journal has consistently operated under an Open Access model, ensuring that groundbreaking research is freely accessible to the global community. With an impressive impact factor, BMC Medicine holds a distinguished Q1 ranking in the field of Medicine (miscellaneous) and ranks #29 out of 636 in General Medicine according to Scopus, placing it in the top 95th percentile of its category. This journal is dedicated to disseminating high-quality research that advances the understanding and practice of medicine, with a comprehensive focus that includes clinical research, public health, and health policy. As part of its commitment to fostering innovation and collaboration in healthcare, BMC Medicine invites researchers, professionals, and students to contribute to this vital platform that addresses the most pressing medical challenges of our time.

Yale Journal of Biology and Medicine, established in 1945, is a distinguished peer-reviewed academic journal published by Yale J Biology Medicine, Inc. This journal serves as an essential platform for the dissemination of high-quality research in the fields of biochemistry, genetics, molecular biology, and medicine. With a notable impact factor and ranking in the top quartiles (Q2) of both biochemistry and medicine categories according to the latest metrics, it underscores its relevance and influence in the academic community. Committed to advancing understanding in these dynamic fields, the journal encourages submissions that contribute to both fundamental and applied scientific knowledge. Although it does not currently follow an open access model, the journal remains highly accessible through various academic databases. Researchers, professionals, and students are invited to explore cutting-edge findings and innovative perspectives that continue to shape the landscape of biology and medicine.

Libyan Journal of Medicine, published by TAYLOR & FRANCIS LTD, is a prominent open-access journal dedicated to advancing the field of medicine, particularly within the context of Libyan and broader Mediterranean health challenges. Since its inception in 2006, the journal has facilitated the dissemination of vital research findings, offering unrestricted access to its rich repository of knowledge, which enhances visibility and accessibility for researchers, clinicians, and students alike. Ranking in the Q3 category within the Medicine (miscellaneous) sector for 2023, and positioned at Rank #147 out of 636 in the general medicine category on Scopus, it reflects a notable recognition for its contributions to medical research. The journal aims not only to publish high-quality articles that span a variety of medical disciplines but also to foster collaboration and communication among the international medical community. As it converges its focus from 2009 to 2024, the Libyan Journal of Medicine serves as an invaluable resource for cutting-edge research and innovative medical practices.

Methods and Protocols is a prestigious open-access journal published by MDPI, focusing on the critical domain of biochemistry, genetics, molecular biology, and biotechnology. Launched in 2018 and based in Basel, Switzerland, the journal provides a vital platform for sharing innovative methodologies and experimental protocols that advance scientific research and development. With an impressive Q2 ranking in multiple categories, including Biochemistry, Genetics and Molecular Biology, and Biotechnology, it fosters a collaborative environment for researchers and professionals to disseminate their findings. With a mission to enhance reproducibility and transparency in scientific inquiry, Methods and Protocols not only serves as an essential resource for academia but also contributes to the practical application of research in various industries. The journal's open-access model ensures that cutting-edge research is accessible to a global audience, thus promoting knowledge sharing and inspiring future innovations within the scientific community.

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

The Journal of Istanbul Faculty of Medicine (Istanbul Tip Fakultesi Dergisi), published by ISTANBUL UNIVERSITY, FACULTY OF MEDICINE, is an esteemed open-access journal that has been committed to disseminating significant medical research since becoming open access in 2017. As a platform for transformative scholarly work, this journal is situated in Turkey and actively engages with diverse medical disciplines to contribute to the collective understanding of health and medicine. Featuring a range of studies that span various facets of medical science, the journal is categorized within the Q4 quartile in Medicine (miscellaneous) for 2023, with its Scopus rankings placing it at #586 out of 636 in the General Medicine category, marking it as a resource that is gaining traction within the academic community. This journal aims to serve as a vital resource for researchers, healthcare professionals, and students alike, fostering the exchange of ideas and innovation in medicine. By providing public access to its content, it underscores the importance of open science in enhancing knowledge sharing and collaboration across borders. For those interested in advancing their research and professional development, the Journal of Istanbul Faculty of Medicine is an invaluable tool for staying informed on the latest findings and discussions in the medical field.